Intracellular TCR-signaling Pathway: Novel Markers for Lymphoma Diagnosis and Potential Therapeutic Targets

No abstract is available for this paper.

• Publication year

  2014

• Venue

  American Journal of Surgical Pathology

• Publication date

  2014-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/PAS.0000000000000309PMID 25118816
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• T cell receptor signalling networks: branched, diversified and bounded

  2013cited by this paper
• Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.

  2013cited by this paper
• CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features

  2013cited by this paper
• Molecular Characteristics of CTA056, a Novel Interleukin-2-Inducible T-Cell Kinase Inhibitor that Selectively Targets Malignant T Cells and Modulates Oncomirs

  2012cited by this paper
• Mice lacking Dok-1, Dok-2, and Dok-3 succumb to aggressive histiocytic sarcoma

  2010cited by this paper
• The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma

  2010cited by this paper
• Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.

  2010cited by this paper
• T-cell signaling regulated by the Tec family kinase, Itk.

  2010cited by this paper
• Origin and pathogenesis of nodular lymphocyte–predominant Hodgkin lymphoma as revealed by global gene expression analysis

  2008cited by this paper
• ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.

  2008cited by this paper
• Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas

  2008cited by this paper
• Novel markers of normal and neoplastic human plasmacytoid dendritic cells.

  2008cited by this paper
• Adaptor SKAP-55 Binds p21ras Activating Exchange Factor RasGRP1 and Negatively Regulates the p21ras-ERK Pathway in T-Cells

  2008cited by this paper
• Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells.

  2008cited by this paper
• Classical PKC isoforms in cancer.

  2007cited by this paper
• PKC isotype functions in T lymphocytes.

  2007cited by this paper
• Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets.

  2007cited by this paper
• Adjusting batch effects in microarray expression data using empirical Bayes methods.

  2007cited by this paper
• RIAM Links the ADAP/SKAP-55 Signaling Module to Rap1, Facilitating T-Cell-Receptor-Mediated Integrin Activation

  2007cited by this paper
• Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation.

  2007cited by this paper
• Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score.

  2006cited by this paper
• Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer.

  2006cited by this paper
• T cell receptor for antigen induces linker for activation of T cell–dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2

  2006cited by this paper
• The Role of Protein Kinase C-Alpha in Hematologic Malignancies

  2006cited by this paper
• Phase II study of PKC-alpha antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancer.

  2006cited by this paper
• Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma

  2006cited by this paper
• Phase II study of PKC-α antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancer

  2006cited by this paper
• TEC-family kinases: regulators of T-helper-cell differentiation

  2005cited by this paper
• A phase I trial of aprinocarsen (ISIS 3521/LY900003), an antisense inhibitor of protein kinase C-α administered as a 24-hour weekly infusion schedule in patients with advanced cancer

  2005cited by this paper
• Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer

  2005cited by this paper
• Phosphotyrosine Binding-Mediated Oligomerization of Downstream of Tyrosine Kinase (Dok)-1 and Dok-2 Is Involved in CD2-Induced Dok Phosphorylation1

  2005influential reference
• Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-alpha delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas.

  2005cited by this paper
• Expression Levels of Protein Kinase C-α in Non–Small-Cell Lung Cancer

  2004cited by this paper
• The Gads (GrpL) Adaptor Protein Regulates T Cell Homeostasis1

  2004cited by this paper
• Characterization of expression of protein kinase C isozymes in human B‐cell lymphoma: Relationship between its expression and prognosis

  2004cited by this paper
• A Phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C alpha, administered as a 21-day infusion to patients with advanced ovarian carcinoma.

  2004cited by this paper
• Expression levels of protein kinase C-alpha in non-small-cell lung cancer.

  2004cited by this paper
• A Phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C α, administered as a 21‐day infusion to patients with advanced ovarian carcinoma

  2004cited by this paper
• Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling.

  2004cited by this paper
• Protein Kinase C Alpha Expression in Breast and Ovarian Cancer

  2004cited by this paper
• Summaries of Affymetrix GeneChip probe level data.

  2003cited by this paper
• Hematopoietic Adaptors in T‐Cell Signaling: Potential Applications to Transplantation

  2003cited by this paper
• Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation.

  2002cited by this paper
• Vascular Endothelial Growth Factor-induced Migration of Multiple Myeloma Cells Is Associated with β1 Integrin- and Phosphatidylinositol 3-Kinase-dependent PKCα Activation*

  2002cited by this paper
• Phosphoinositide 3-Kinase–Dependent Membrane Recruitment of P62dok Is Essential for Its Negative Effect on Mitogen-Activated Protein (Map) Kinase Activation

  2001cited by this paper
• The role of Gads in hematopoietic cell signalling

  2001cited by this paper
• Positive and negative regulation of t-cell activation by adaptor proteins

  2001cited by this paper
• Protein kinase C-alpha is essential for Ramos-BL B cell survival.

  1999cited by this paper
• Protein Kinase C-α Is Essential for Ramos-BL B Cell Survival

  1999cited by this paper
• RA70 is a src kinase-associated protein expressed ubiquitously.

  1998cited by this paper
• FRIP, a hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation.

  1998cited by this paper
• Regulatory intramolecular association in a tyrosine kinase of the Tec family

  1997cited by this paper

• Sequential transcriptome profiling: comparative analysis of normal and canine lymphoma preceding detailed T-cell and B-cell subtype comparison

  2025cites this paper
• Role of cytokine in malignant T-cell metabolism and subsequent alternation in T-cell tumor microenvironment

  2023cites this paper
• Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell Lymphomas

  2022cites this paper
• Signal Transduction in Immune Cells and Protein Kinases.

  2021cites this paper
• Targeting ITK signaling for T cell-mediated diseases

  2021cites this paper
• Ontogeny, Genetics, Molecular Biology and Classification of B and T cell Non-Hodgkin’s Lymphoma

  2020cites this paper
• Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis

  2020cites this paper
• The new biology of PTCL‐NOS and AITL: current status and future clinical impact

  2020influential citation
• Adaptor proteins: Flexible and dynamic modulators of immune cell signalling

  2020cites this paper
• Structural and diffusion weighted MRI demonstrates responses to ibrutinib in a mouse model of follicular helper (Tfh) T-cell lymphoma

  2019cites this paper
• Genetic alterations affecting GTPases and T-cell receptor signaling in peripheral T-cell lymphomas

  2019cites this paper
• ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma

  2019cites this paper
• Interleukin-2-inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells.

  2019cites this paper
• Ontogeny, Genetics, Molecular Biology, and Classification of B- and T-Cell Non-Hodgkin Lymphoma.

  2019cites this paper
• Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma

  2019cites this paper
• Characterising interleukin-2-inducible kinase (ITK) inhibitors and their potential for moulding CD4 T-cell plasticity

  2018cites this paper
• Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma

  2018cites this paper
• Expression of T‐cell receptor signalling pathway components in extranodal NK/T‐cell lymphoma

  2018cites this paper
• T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy

  2016cites this paper
• Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma.

  2016cites this paper
• Conserved Molecular Underpinnings and Characterization of a Role for Caveolin-1 in the Tumor Microenvironment of Mature T-Cell Lymphomas

  2015cites this paper